Skip to main content
logo
Abbott Laboratories (ABT)
NYSE: ABT · Real-Time Price · USD
106.20
+1.63 (1.56%)
At close: Oct 30, 2026, 4:00 PM EDT
105.90
-0.30 (-0.28%)
After-hours: Oct 30, 2026, 7:38 PM EDT

Abbott Laboratories Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
6,52413,4025,7236,9337,071
Depreciation & Amortization
3,1163,2183,2433,2673,538
Loss (Gain) From Sale of Assets
6548212621555
Stock-Based Compensation
664673644685640
Change in Accounts Receivable
-652-691-356-68-383
Change in Inventory
195-58-232-1,413-456
Change in Accounts Payable
954356-7604201,288
Change in Income Taxes
-5-8,028-585-383-908
Change in Other Net Operating Assets
-1,295-796-542-75-312
Operating Cash Flow
9,5668,5587,2619,58110,533
Operating Cash Flow Growth
11.78%17.86%-24.21%-9.04%33.31%

Investing Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-2,171-2,207-2,202-1,777-1,885
Cash Acquisitions
-105--877--187
Divestitures
-14048134
Investment in Securities
-164-141-116-33-96
Other Investing Activities
189222226
Investing Cash Flow
-2,422-2,338-3,133-1,740-2,008

Financing Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
--2147-
Long-Term Debt Issued
5223274
Total Debt Issued
522323544
Short-Term Debt Repaid
-115-100---204
Long-Term Debt Repaid
-1,504-660-2,498-753-48
Total Debt Repaid
-1,619-760-2,498-753-252
Net Debt Issued (Repaid)
-1,614-537-2,475-699-248
Issuance of Common Stock
396264167167255
Repurchase of Common Stock
-893-1,295-1,227-3,795-2,299
Common Dividends Paid
-4,116-3,836-3,556-3,309-3,202
Other Financing Activities
-82----
Financing Cash Flow
-6,309-5,404-7,091-7,636-5,494

Net Cash Flow

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
71-96-23-122-70
Net Cash Flow
906720-2,986832,961

Free Cash Flow

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
7,3956,3515,0597,8048,648
Free Cash Flow Growth
16.44%25.54%-35.17%-9.76%51.08%
Free Cash Flow Margin
16.68%15.14%12.61%17.88%20.08%
Free Cash Flow Per Share
4.233.632.894.424.83
Levered Free Cash Flow
6,2895,6104,9907,3407,675
Unlevered Free Cash Flow
6,5975,9595,3897,6898,009

Additional Metrics

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
545604662563544
Cash Income Tax Paid
1,9331,7231,4751,8641,941
Change in Working Capital
-803-9,217-2,475-1,519-771
SEC Filings: 10-K · 10-Q